Literature DB >> 32666516

Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study.

Anna Rita Di Biase1, Giovanni Marasco2, Federico Ravaioli2, Elton Dajti2, Luigi Colecchia2, Beatrice Righi1, Virginia D'Amico1, Davide Festi2, Lorenzo Iughetti1, Antonio Colecchia3.   

Abstract

BACKGROUND AND AIM: Recent researches have shown an altered gut microbiota in celiac disease (CD) patients compared with healthy controls (HCs). This study aims to evaluate the composition of the microbiota of CD children at onset and the relationship between bacterial abundances and symptoms.
METHODS: Celiac disease patients were consecutively enrolled at a pediatric unit referring for suspected CD. HCs were also included in the study. Stool and duodenal samples were collected and evaluated by a high taxonomic fingerprint microbiota array.
RESULTS: Thirty-seven subjects enrolled: 21 CD patients and 16 HCs. Fourteen subjects were male (38%). The mean age was 75 months (standard deviation 31.5) for CD patients and 71 months (standard deviation 34.9) for HCs. Duodenal microbiota of CD patients showed a dominance of Enterobacteriaceae and subdominance of Bacteroidetes/Streptococcus. Stool microbiota showed a lower abundance of Bacteroides-Prevotella (P = 0.013), Akkermansia (P = 0.002), and Staphylococcaceae (P = 0.001) in CD patients compared with HC. At symptoms level, an increased mean relative abundance of Bacillaceae and Enterobaeriaceae in patients with abdominal pain (P = 0.007 and P = 0.010) was found. CD patients with diarrhea had reduced mean relative abundance of Clostridium cluster XIVa (P = 0.044) and Akkermansia (P = 0.033) and an increase in Bacillaceae (P = 0.048) and Fusobacterium (P = 0.048).
CONCLUSIONS: Gut microbiota of CD children at disease onset is different from that of HC. Pro-inflammatory microbiota imbalances were associated with CD symptoms. Further studies are needed to assess whether dysbiosis is associated with CD early onset and symptoms.
© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Akkermansia; diarrhea; duodenal microbiota; stool microbiota

Year:  2020        PMID: 32666516     DOI: 10.1111/jgh.15183

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

Review 1.  Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract.

Authors:  Aline C Fenneman; Melissa Weidner; Lea Ann Chen; Max Nieuwdorp; Martin J Blaser
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-18       Impact factor: 73.082

2.  Fecal and Duodenal Microbiota in Pediatric Celiac Disease.

Authors:  Diyora Abdukhakimova; Kuanysh Dossybayeva; Dimitri Poddighe
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

3.  Isomaltulose Exhibits Prebiotic Activity, and Modulates Gut Microbiota, the Production of Short Chain Fatty Acids, and Secondary Bile Acids in Rats.

Authors:  Zhan-Dong Yang; Yi-Shan Guo; Jun-Sheng Huang; Ya-Fei Gao; Fei Peng; Ri-Yi Xu; Hui-Hui Su; Ping-Jun Zhang
Journal:  Molecules       Date:  2021-04-23       Impact factor: 4.411

Review 4.  Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients.

Authors:  Giovanni Marasco; Giovanna Grazia Cirota; Benedetta Rossini; Lisa Lungaro; Anna Rita Di Biase; Antonio Colecchia; Umberto Volta; Roberto De Giorgio; Davide Festi; Giacomo Caio
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

5.  Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients.

Authors:  Guo-Hua Li; Shi-Jia Huang; Xiang Li; Xiao-Song Liu; Qiao-Ling Du
Journal:  World J Gastroenterol       Date:  2020-12-14       Impact factor: 5.742

6.  Lack of Effect of Gluten Challenge on Fecal Microbiome in Patients With Celiac Disease and Non-Celiac Gluten Sensitivity.

Authors:  Yael R Nobel; Felix Rozenberg; Heekuk Park; Daniel E Freedberg; Martin J Blaser; Peter H R Green; Anne-Catrin Uhlemann; Benjamin Lebwohl
Journal:  Clin Transl Gastroenterol       Date:  2021-12-20       Impact factor: 4.488

7.  Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years.

Authors:  Anna Rita Di Biase; Giovanni Marasco; Federico Ravaioli; Luigi Colecchia; Elton Dajti; Marco Lecis; Erica Passini; Luigina Vanessa Alemanni; Davide Festi; Lorenzo Iughetti; Antonio Colecchia
Journal:  Nutrients       Date:  2021-11-18       Impact factor: 5.717

8.  Effects of Probiotic Bacteria Lactobacillaceae on the Gut Microbiota in Children With Celiac Disease Autoimmunity: A Placebo-Controlled and Randomized Clinical Trial.

Authors:  Elin Oscarsson; Åsa Håkansson; Carin Andrén Aronsson; Göran Molin; Daniel Agardh
Journal:  Front Nutr       Date:  2021-06-25

Review 9.  Contribution of Infectious Agents to the Development of Celiac Disease.

Authors:  Daniel Sánchez; Iva Hoffmanová; Adéla Szczepanková; Věra Hábová; Helena Tlaskalová-Hogenová
Journal:  Microorganisms       Date:  2021-03-06

10.  Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study.

Authors:  Maureen M Leonard; Francesco Valitutti; Hiren Karathia; Meritxell Pujolassos; Victoria Kenyon; Brian Fanelli; Jacopo Troisi; Poorani Subramanian; Stephanie Camhi; Angelo Colucci; Gloria Serena; Salvatore Cucchiara; Chiara Maria Trovato; Basilio Malamisura; Ruggiero Francavilla; Luca Elli; Nur A Hasan; Ali R Zomorrodi; Rita Colwell; Alessio Fasano
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.